| Patient | Duke Kahanamoku |
|---|---|
| Date of birth | 1959-08-24 |
| Identifiers | MRN HR-ML050-SYN; SSN (made up) 000-50-6847 |
| Document date | 2026-03-16 |
| Author | Kawika Lindgren-Morrison, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care for six weeks of breathlessness, ankle swelling and tiredness five years after a heart attack: examination, ECG, chest X-ray, NT-proBNP and laboratory tests, a diuretic, and the plan for an echocardiogram [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1952 | Heart attack in 1952, at about 61, one of several in his later years; details of its treatment are not recorded in the sources read | D (CLM-0009) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 2021-06-21 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2021-06-21 to 2026-03-16 | completed | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-16 | active | S |
| Metoprolol tartrate 25 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 2021-06-21 to 2026-03-30 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2021-06-21 to 2026-03-30 | completed | S |
| Furosemide 40 mg oral tablet, one tablet every morning | One tablet every morning | Oral route | 2026-03-16 to 2026-04-27 | completed | S |
Positive for the concerns in the history of present illness. Alert, calm and courteous; frustrated at being kept from the water; mood steady; PHQ-2 score 1. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in all daily activities; breathless walking up a gentle slope or paddling out through small surf; has stopped his morning swim after a few minutes; sleeps on two pillows; NYHA class III. [S]
Vital signs recorded on 2026-03-16; see the Vital Signs section. Mental status: Alert, calm and courteous; frustrated at being kept from the water; mood steady; PHQ-2 score 1. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-16 | Body height | 185 | cm | S |
| 2026-03-16 | Body weight | 97.6 | kg | S |
| 2026-03-16 | Body mass index (BMI) [Ratio] | 28.5 | kg/m2 | S |
| 2026-03-16 | Systolic blood pressure | 142 | mm[Hg] | S |
| 2026-03-16 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-03-16 | Heart rate | 92 | /min | S |
| 2026-03-16 | Respiratory rate | 20 | /min | S |
| 2026-03-16 | Body temperature | 36.7 | Cel | S |
| 2026-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-16 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 2450 | pg/mL | Below 125 pg/mL makes heart failure unlikely outside the hospital | High | S |
| 2026-03-16 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-16 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 1.02 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 81 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-16 | Glucose [Mass/volume] in Serum or Plasma | 102 | mg/dL | 70-99 mg/dL | High | S |
| 2026-03-16 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 2026-03-16 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-03-16 | Ferritin [Mass/volume] in Serum or Plasma | 62 | ng/mL | In heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiency | Low | S |
| 2026-03-16 | Iron saturation [Mass Fraction] in Serum or Plasma | 16 | % | 20-50% | Low | S |
| 2026-03-16 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-03-16 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | <=5.6% | High | S |
| 2026-03-16 | Cholesterol [Mass/volume] in Serum or Plasma | 168 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-03-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 92 | mg/dL | Secondary-prevention goal below 70 mg/dL | High | S |
| 2026-03-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-03-16 | Triglyceride [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=149 mg/dL | High | S |
| 2026-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-55 U/L | Normal | S |
| 2026-03-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-03-16 | Overall summary score [KCCQ-12] | 38 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determined | active | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology established heart failure with reduced ejection fraction. |
| Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1952 | active | confirmed | I25.2 | S — Synthetic modern diagnosis; the 1952 heart attack remains D in the history. |
| Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%) | active | confirmed | E61.1 | S — Synthetic finding at the heart failure workup. |